ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04622	RIG-I-like receptor signaling pathway	2/6	62/7206	0.00106861357555
ko05140	Leishmaniasis	2/6	75/7206	0.00156060829431
ko04657	IL-17 signaling pathway	2/6	87/7206	0.00209450022276
ko05133	Pertussis	2/6	87/7206	0.00209450022276
ko05222	Small cell lung cancer	2/6	89/7206	0.00219084785916
ko04064	NF-kappa B signaling pathway	2/6	96/7206	0.00254450322645
ko04620	Toll-like receptor signaling pathway	2/6	100/7206	0.00275801522871
ko05162	Measles	2/6	120/7206	0.00394869822506
ko05145	Toxoplasmosis	2/6	126/7206	0.00434545099759
ko05142	Chagas disease (American trypanosomiasis)	2/6	130/7206	0.00461997421133
ko04380	Osteoclast differentiation	2/6	134/7206	0.00490247029118
ko04120	Ubiquitin mediated proteolysis	2/6	138/7206	0.00519290143871
ko05160	Hepatitis C	2/6	153/7206	0.0063520475231
ko04621	NOD-like receptor signaling pathway	2/6	157/7206	0.00667965705713
ko04722	Neurotrophin signaling pathway	2/6	160/7206	0.00693043224029
ko05168	Herpes simplex infection	2/6	182/7206	0.0089006457067
ko05152	Tuberculosis	2/6	187/7206	0.00938023546445
ko05169	Epstein-Barr virus infection	2/6	206/7206	0.0113081407184
ko00531	Glycosaminoglycan degradation	1/6	23/7206	0.0190050861484
ko05166	HTLV-I infection	2/6	292/7206	0.0220304097941
ko01523	Antifolate resistance	1/6	30/7206	0.024729130984
ko04010	MAPK signaling pathway	2/6	321/7206	0.0263425454951
ko04623	Cytosolic DNA-sensing pathway	1/6	41/7206	0.0336678118474
ko05321	Inflammatory bowel disease (IBD)	1/6	56/7206	0.0457468110124